• Investigadors principals: Diana Puente Baliarda
• Còdi: 9F-0-00019-25
• Any d’inici: 2025

Post-authorisation safety study to evaluate the utilisation and safety of atogepant in patients with migraine and significant cardiovascular and/or cerebrovascular disease in European countries

• Investigadors principals: Talita Duarte Salles
• Còdi: 4RNC-0-00113-24
• Any d’inici: 2025
• Finançadors: Pharmo Institute N.V.

Atlas de prescripción farmacéutica en Diabetes

• Investigadors principals: Anna Moleras Serra, Anna Berenguera Ossó
• Còdi: 4RNC-0-00238-24
• Any d’inici: 2025

Atlas para la monitorización de los cuidados en Diabetes

• Investigadors principals: Anna Moleras Serra, Anna Berenguera Ossó
• Còdi: 4RNC-0-00270-24
• Any d’inici: 2025

Regional Research Protocol to evaluate the effectiveness of dengue vaccines and the risk of Vaccine-Associated Enhanced Disease (VAED) in the Americas.

• Investigadors principals: Felipe Villalobos Martínez
• Còdi: 4RNC-0-00340-25
• Any d’inici: 2025
• Finançadors: American Health Organization/World Health Organization (PAHO/OPS)